{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:22:45Z","timestamp":1779927765702,"version":"3.53.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21221001"],"award-info":[{"award-number":["21221001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600131"],"award-info":[{"award-number":["81600131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21401192"],"award-info":[{"award-number":["21401192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602974"],"award-info":[{"award-number":["81602974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["QYZDJ-SSW-SLH033"],"award-info":[{"award-number":["QYZDJ-SSW-SLH033"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB20000000"],"award-info":[{"award-number":["XDB20000000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2016J01084"],"award-info":[{"award-number":["2016J01084"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2018J05145"],"award-info":[{"award-number":["2018J05145"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2017J01360"],"award-info":[{"award-number":["2017J01360"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.phrs.2019.104264","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:09:02Z","timestamp":1557335342000},"page":"104264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis"],"prefix":"10.1016","volume":"145","author":[{"given":"Pan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feitai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghui","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2019.104264_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6079","key":"10.1016\/j.phrs.2019.104264_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/322547a0","article-title":"Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage","volume":"322","author":"Saklatvala","year":"1986","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2019.104264_bib0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0167-4889(90)90145-4","article-title":"Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes","volume":"1052","author":"Lefebvre","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.phrs.2019.104264_bib0020","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar2401","article-title":"Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis","volume":"10","author":"Richardson","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2019.104264_bib0025","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar2099","article-title":"The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis","volume":"8","author":"Bondeson","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2019.104264_bib0030","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1172\/JCI118636","article-title":"The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis","volume":"97","author":"Reboul","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"41","key":"10.1016\/j.phrs.2019.104264_bib0035","doi-asserted-by":"crossref","first-page":"39762","DOI":"10.1074\/jbc.M303541200","article-title":"Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes","volume":"278","author":"Chadjichristos","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2019.104264_bib0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/papr.12551","article-title":"Degenerative joint diseases and neuroinflammation","volume":"17","author":"Fusco","year":"2017","journal-title":"Pain Pract."},{"key":"10.1016\/j.phrs.2019.104264_bib0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1744-8069-7-88","article-title":"The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain","volume":"7","author":"Sagar","year":"2011","journal-title":"Mol. Pain"},{"issue":"10","key":"10.1016\/j.phrs.2019.104264_bib0050","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1002\/art.23866","article-title":"Spinal interleukin-1beta in a mouse model of arthritis and joint pain","volume":"58","author":"Fiorentino","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.phrs.2019.104264_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14656566.2017.1414802","article-title":"Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage","volume":"19","author":"Maniar","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.phrs.2019.104264_bib0060","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.2008.094284","article-title":"Erosive osteoarthritis of the hand: clinical experience with anakinra","volume":"68","author":"Bacconnier","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2019.104264_bib0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheumatism"},{"issue":"8","key":"10.1016\/j.phrs.2019.104264_bib0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cbdv.200790159","article-title":"The N-acylethanolamine-hydrolyzing acid amidase (NAAA)","volume":"4","author":"Tsuboi","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"12","key":"10.1016\/j.phrs.2019.104264_bib0075","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1074\/jbc.M413473200","article-title":"Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase","volume":"280","author":"Tsuboi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104264_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2014.04.011","article-title":"Advances in the discovery of N-acylethanolamine acid amidase inhibitors","volume":"86","author":"Bandiera","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2019.104264_bib0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biochi.2010.01.006","article-title":"N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities","volume":"92","author":"Petrosino","year":"2010","journal-title":"Biochimie."},{"issue":"3","key":"10.1016\/j.phrs.2019.104264_bib0090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha","volume":"319","author":"LoVerme","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"49","key":"10.1016\/j.phrs.2019.104264_bib0095","doi-asserted-by":"crossref","first-page":"20966","DOI":"10.1073\/pnas.0907417106","article-title":"Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation","volume":"106","author":"Solorzano","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104264_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2014.10.008","article-title":"Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain","volume":"91","author":"Petrosino","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104264_bib0105","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1038\/srep13565","article-title":"Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-alpha","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2019.104264_bib0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1124\/jpet.115.230516","article-title":"An important role for N-acylethanolamine acid amidase in the complete freund\u2019s adjuvant rat model of arthritis","volume":"356","author":"Bonezzi","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"37","key":"10.1016\/j.phrs.2019.104264_bib0115","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1002\/anie.201603746","article-title":"Second-generation non-covalent NAAA inhibitors are protective in a model of multiple sclerosis","volume":"55","author":"Migliore","year":"2016","journal-title":"Angew. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2019.104264_bib0120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbalip.2017.01.001","article-title":"N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation","volume":"1862","author":"Alhouayek","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.phrs.2019.104264_bib0125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1096\/fj.14-255208","article-title":"N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis","volume":"29","author":"Alhouayek","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.104264_bib0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejmech.2016.11.039","article-title":"Progress in the development of beta-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: synthesis and SAR study of new, potent N-O-substituted derivatives","volume":"126","author":"Petracca","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2019.104264_bib0135","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.drudis.2018.03.007","article-title":"N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities","volume":"23","author":"Bottemanne","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"21","key":"10.1016\/j.phrs.2019.104264_bib0140","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1039\/C6RA28734D","article-title":"Design, synthesis, and biological evaluation of oxazolidone derivatives as highly potent N-acylethanolamine acid amidase (NAAA) inhibitors","volume":"7","author":"Ren","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.phrs.2019.104264_bib0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2018.03.011","article-title":"Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215","volume":"132","author":"Li","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104264_bib0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejmech.2017.08.004","article-title":"Identification of highly potent N -acylethanolamine acid amidase (NAAA) inhibitors: optimization of the terminal phenyl moiety of oxazolidone derivatives","volume":"139","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2019.104264_bib0155","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.joca.2016.06.012","article-title":"Relationship between structural pathology and pain behaviour in a model of osteoarthritis (OA)","volume":"24","author":"Nwosu","year":"2016","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.phrs.2019.104264_bib0160","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm.3143","article-title":"Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis","volume":"19","author":"Zhen","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2019.104264_bib0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5604\/17322693.1194616","article-title":"Effect of methylprednisolone, hyaluronic acid and pioglitazone on histological remodeling of temporomandibular joint cartilage in rabbits affected by drug-induced osteoarthritis","volume":"70","author":"Kaluzynski","year":"2016","journal-title":"Postepy higieny i medycyny doswiadczalnej"},{"key":"10.1016\/j.phrs.2019.104264_bib0170","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1038\/ncomms15889","article-title":"DOT1L safeguards cartilage homeostasis and protects against osteoarthritis","volume":"8","author":"Monteagudo","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.phrs.2019.104264_bib0175","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2055","article-title":"Modulating hedgehog signaling can attenuate the severity of osteoarthritis","volume":"15","author":"Lin","year":"2009","journal-title":"Nat. Med."},{"issue":"37","key":"10.1016\/j.phrs.2019.104264_bib0180","doi-asserted-by":"crossref","first-page":"22699","DOI":"10.1039\/C7RA02237A","article-title":"Design and synthesis of uracil urea derivatives as potent and selective fatty acid amide hydrolase inhibitors","volume":"7","author":"Qiu","year":"2017","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.phrs.2019.104264_bib0185","article-title":"Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.phrs.2019.104264_bib0190","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nprot.2008.95","article-title":"Primary culture and phenotyping of murine chondrocytes","volume":"3","author":"Gosset","year":"2008","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.phrs.2019.104264_bib0195","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104264_bib0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s13075-016-1189-5","article-title":"Adelmidrol, in combination with hyaluronic acid, displays increased anti-inflammatory and analgesic effects against monosodium iodoacetate-induced osteoarthritis in rats","volume":"18","author":"Di Paola","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2019.104264_bib0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.joca.2011.03.010","article-title":"Peroxisome proliferator activated receptor alpha activation decreases inflammatory and destructive responses in osteoarthritic cartilage","volume":"19","author":"Clockaerts","year":"2011","journal-title":"Osteoarthr. Cartil."},{"issue":"10","key":"10.1016\/j.phrs.2019.104264_bib0210","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/bph.14339","article-title":"PPARs and pain","volume":"176","author":"Okine","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104264_bib0215","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/j.1532-2149.2012.00223.x","article-title":"Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl\/6 mice","volume":"17","author":"Ogbonna","year":"2013","journal-title":"Eur. J. Pain"},{"issue":"19","key":"10.1016\/j.phrs.2019.104264_bib0220","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1073\/pnas.1514854113","article-title":"Interaction of HIF1alpha and beta-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice","volume":"113","author":"Bouaziz","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.phrs.2019.104264_bib0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/138945010791011938","article-title":"NF-kappaB signaling: multiple angles to target OA","volume":"11","author":"Marcu","year":"2010","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.phrs.2019.104264_bib0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1759720X12468659","article-title":"Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review","volume":"5","author":"van Eekeren","year":"2013","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2019.104264_bib0235","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00296-013-2766-4","article-title":"Treatment of erosive osteoarthritis with peroxisome proliferator-activated receptor alpha agonist fenofibrate: a pilot study","volume":"34","author":"Shirinsky","year":"2014","journal-title":"Rheumatol. Int."},{"issue":"36","key":"10.1016\/j.phrs.2019.104264_bib0240","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1073\/pnas.1111101108","article-title":"NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104264_bib0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuropharm.2018.11.013","article-title":"Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward","volume":"144","author":"Sagheddu","year":"2019","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819304670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819304670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:31:19Z","timestamp":1778581879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819304670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":49,"alternative-id":["S1043661819304670"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104264","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104264"}}